
About Srihaas Lifesciences
Srihaas Lifesciences is a Healthcare company based in Hyderabad (India) founded in 2018. It manufactures and supplies pharmaceutical intermediates and specialty chemicals. It operates on a B2B model. The company has 15 employees. Its Indian entity Sri Haas Life Sciences Private Limited reported revenue of βΉ28.99 Cr. Its focus areas include Pharmaceuticals, Manufacturing and API Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Srihaas Lifesciences, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api intermediates. Manufactures and supplies pharmaceutical intermediates and specialty chemicals. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hyderabad, India
- Employees 15
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website srihaaslifesciences.com
- Legal Name Sri Haas Life Sciences Private Limited
- Date of Incorporation 12 Jun, 2018
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹28.99 Cr
FY 2025 · +60% YoY
- Net Profit₹4.32 Cr
FY 2025 · 15% margin
- EBITDA₹7.28 Cr
FY 2025 · 25% margin
- Employee Count15
Associated legal entities of Srihaas Lifesciences
Srihaas Lifesciences operates through Sri Haas Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sri Haas Life Sciences Private Limited CIN U24290TG2018PTC125040 | Active | 12 Jun 2018 | Hyderabad, Telangana | ₹29.0 Cr | 15 | 2 | View details |
Board of directors of Sri Haas Life Sciences Private Limited (Srihaas Lifesciences)
Sri Haas Life Sciences Private Limited is the primary company behind Srihaas Lifesciences. The board of Sri Haas Life Sciences Private Limited currently have 2 directors; the longest-serving is Mudunuru Raju Sasikumar, appointed in 2018. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mudunuru Raju Sasikumar DIN 03059826 | Managing Director | 12 Jun 2018 | 8 yrs 5 mo | Sri Haas Life Sciences Private Limited |
| Devi Vasundara Kutcherlapati DIN 08803803 | Director | 23 Jul 2020 | 6 yrs 3 mo | Sri Haas Life Sciences Private Limited |
Financials of Srihaas Lifesciences
Figures of Sri Haas Life Sciences Private Limited, the primary company behind Srihaas Lifesciences, for FY 2025. Revenue was ₹28.99 Cr (+60% year on year). Net profit was ₹4.32 Cr (15% margin). EBITDA was ₹7.28 Cr (25% margin). Revenue has grown at a compounded annual rate of +8% over three years and +32% over five years.
- ₹28.99 CrRevenue · FY 2025 · +60% YoY
- ₹4.32 CrNet profit · 15% margin
- ₹7.28 CrEBITDA · 25% margin
- ₹34 LakhPaid-up capital
- 15Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +32%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sri Haas Life Sciences Private Limited are on its company page.
Detailed financial statements for Srihaas Lifesciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Srihaas Lifesciences
Srihaas Lifesciences has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Srihaas Lifesciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Srihaas Lifesciences
Srihaas Lifesciences was founded in 2018.
Srihaas Lifesciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Srihaas Lifesciences has 15 employees.
The primary company behind Srihaas Lifesciences, Sri Haas Life Sciences Private Limited, reported revenue of βΉ28.99 Cr for FY 2025, up 60% year on year.
Srihaas Lifesciences, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api intermediates. Manufactures and supplies pharmaceutical intermediates and specialty chemicals. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Srihaas Lifesciences's top competitors include Laurus Labs, Symbiotec and SeQuent.
Srihaas Lifesciences operates through Sri Haas Life Sciences Private Limited.
The legal entities of Srihaas Lifesciences currently have 2 directors, including Mudunuru Raju Sasikumar, Devi Vasundara Kutcherlapati.